84 related articles for article (PubMed ID: 8993798)
1. Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer.
Bautista D; Obrador A; Moreno V; Cabeza E; Canet R; Benito E; Bosch X; Costa J
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):57-61. PubMed ID: 8993798
[TBL] [Abstract][Full Text] [Related]
2. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study.
Slattery ML; Curtin K; Anderson K; Ma KN; Edwards S; Leppert M; Potter J; Schaffer D; Samowitz WS
Cancer Res; 2000 Dec; 60(24):6935-41. PubMed ID: 11156393
[TBL] [Abstract][Full Text] [Related]
3. Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutation.
Laso N; Mas S; Jose Lafuente M; Casterad X; Trias M; Ballesta A; Molina R; Salas J; Ascaso C; Zheng S; Wiencke JK; Lafuente A
Anticancer Res; 2004; 24(3b):2011-20. PubMed ID: 15274393
[TBL] [Abstract][Full Text] [Related]
4. Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study.
Brink M; Weijenberg MP; De Goeij AF; Schouten LJ; Koedijk FD; Roemen GM; Lentjes MH; De Bruïne AP; Goldbohm RA; Van Den Brandt PA
Carcinogenesis; 2004 Sep; 25(9):1619-28. PubMed ID: 15117813
[TBL] [Abstract][Full Text] [Related]
5. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
6. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas.
Martínez ME; Maltzman T; Marshall JR; Einspahr J; Reid ME; Sampliner R; Ahnen DJ; Hamilton SR; Alberts DS
Cancer Res; 1999 Oct; 59(20):5181-5. PubMed ID: 10537295
[TBL] [Abstract][Full Text] [Related]
9. Distinctive clinicopathological features of Ki-ras mutated colorectal cancers.
Lin JK; Chang SC; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC; Li AF
J Surg Oncol; 2006 Sep; 94(3):234-41. PubMed ID: 16900509
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas.
Ishii M; Sugai T; Habano W; Nakamura S
J Gastroenterol; 2004 Jun; 39(6):544-9. PubMed ID: 15235871
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292).
Wadler S; Bajaj R; Neuberg D; Agarwal V; Haynes H; Benson AB
Cancer J Sci Am; 1997; 3(5):284-8. PubMed ID: 9327152
[TBL] [Abstract][Full Text] [Related]
13. Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene.
Tomita S; Kawamata H; Imura J; Omotehara F; Ueda Y; Fujimori T
Int J Mol Med; 2002 May; 9(5):485-8. PubMed ID: 11956653
[TBL] [Abstract][Full Text] [Related]
14. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
Weijenberg MP; Aardening PW; de Kok TM; de Goeij AF; van den Brandt PA
Mutat Res; 2008 Mar; 652(1):54-64. PubMed ID: 18296105
[TBL] [Abstract][Full Text] [Related]
15. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689
[TBL] [Abstract][Full Text] [Related]
16. Identification of mutations in the Ki-ras gene in human retinoblastoma.
Bautista D; Emanuel JR; Granville C; Howard R; Costa J
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2313-7. PubMed ID: 8843915
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese.
Wong HL; Seow A; Arakawa K; Lee HP; Yu MC; Ingles SA
Carcinogenesis; 2003 Jun; 24(6):1091-5. PubMed ID: 12807755
[TBL] [Abstract][Full Text] [Related]
18. Colorectal adenomas with a low frequency of ki-ras mutations: a sample from a population with a low mortality rate from colorectal cancer.
Kornaros S; Liloglou T; Politou M; Elemenoglou I
Colorectal Dis; 2005 Jul; 7(4):323-6. PubMed ID: 15932552
[TBL] [Abstract][Full Text] [Related]
19. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
20. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
